Scholars Central

EditorialPublished May 2021

Dyslipidemia : Classification, Screening

Authors: Graeme Bell

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dyslipidemia is an abnormal amount of lipids (e.g., triglycerides, cholesterol and/or fat phospholipids) within the blood. Dyslipidemia may be a risk factor for the event of atherosclerotic disorder (ASCVD). ASCVD includes arteriacoronaria disease, cerbrovascular disease, and peripheral artery disease. Although dyslipidemia may be a risk factor for ASCVD, abnormal levels don’t suggest that lipid lowering agents got to be started. Other factors, like comorbid conditions and lifestyle additionally to dyslipidemia, is taken into account during a cardiovascular risk assessment. In developed countries, most dyslipidemias are hyperlipidemias; that’s , an elevation of lipids within the blood. this is often often thanks to diet and lifestyle. Prolonged elevation of insulin resistance also can cause dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical Nutrition and Metabolism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Nutrition and Metabolism
  • SubjectDiabetes & Endocrinology
  • SubjectNutrition & Food Science
  • BylineArticles whose byline prints “Graeme Bell”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels